Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Smartphone App Shows Promise for Neurological Screening at Home
05/24/2022
Jolynn Tumolo
A smartphone-based app that provides pupil measurements comparable to a gold-standard pupillometer could allow for the screening of Alzheimer disease and other neurological conditions at home.
A smartphone-based app that provides pupil measurements comparable to a gold-standard pupillometer could allow for the screening of Alzheimer disease and other neurological conditions at home.
A smartphone-based app that...
05/24/2022
Neurology
News
Children’s Sleep Habits Changed During COVID-19 Lockdown
05/24/2022
Jolynn Tumolo
Home confinement during the initial months of the COVID-19 pandemic was associated with delayed bedtimes and wake times, increased sleep latency, and daytime sleepiness in children, according to a systematic review.
Home confinement during the initial months of the COVID-19 pandemic was associated with delayed bedtimes and wake times, increased sleep latency, and daytime sleepiness in children, according to a systematic review.
Home confinement during the...
05/24/2022
Neurology
News
Week-Long Break From Social Media Provides Mental Health Boost
05/24/2022
Jolynn Tumolo
Asking people to take a week-long break from social media significantly improved well-being, depression, and anxiety, according to results from a randomized clinical trial.
Asking people to take a week-long break from social media significantly improved well-being, depression, and anxiety, according to results from a randomized clinical trial.
Asking people to take a...
05/24/2022
Psych Congress Network
News
Real-World Data Shows Effectiveness of Secukinumab for PsA, axSpA
05/23/2022
Jolynn Tumolo
Findings show secukinumab is an effective and safe treatment for patients with axial spondyloarthritis and psoriatic arthritis. 
Findings show secukinumab is an effective and safe treatment for patients with axial spondyloarthritis and psoriatic arthritis. 
Findings show secukinumab is an...
05/23/2022
First Report Managed Care
News
Multimodality Treatment vs Androgen Deprivation Therapy Alone in Patients With Oligometastatic Prostate Cancer 
05/20/2022
Jolynn Tumolo
Researchers compared the effects of multimodality treatment vs androgen deprivation therapy alone in treating patients with oligometastatic prostate cancer.
Researchers compared the effects of multimodality treatment vs androgen deprivation therapy alone in treating patients with oligometastatic prostate cancer.
Researchers compared the effects...
05/20/2022
First Report Managed Care
News
Voice-Focused Speech Therapy Improves Voice Quality in Patients With Parkinson Disease
05/20/2022
Jolynn Tumolo
Study authors investigated effects of intensive speech treatment targeting articulation on voice quality or targeting voice among patients with Parkinson disease measured by the Acoustic Voice Quality Index. 
Study authors investigated effects of intensive speech treatment targeting articulation on voice quality or targeting voice among patients with Parkinson disease measured by the Acoustic Voice Quality Index. 
Study authors investigated...
05/20/2022
Annals of Long-Term Care
News
Class I Recall for Compounding Product
05/19/2022
Jolynn Tumolo
A Class I recall has been issued for a product used in extemporaneous compounding of prescriptions for oral dosing.
A Class I recall has been issued for a product used in extemporaneous compounding of prescriptions for oral dosing.
A Class I recall has been issued...
05/19/2022
Pharmacy Learning Network
News
Antidepressant Recalled After Customer Report
05/19/2022
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is voluntarily recalling a prescription antidepressant following a customer report of a dark, gritty substance in a bottle of medication.
Sun Pharmaceutical Industries Inc is voluntarily recalling a prescription antidepressant following a customer report of a dark, gritty substance in a bottle of medication.
Sun Pharmaceutical Industries...
05/19/2022
Pharmacy Learning Network
News
Cancer Drug Recalled
05/19/2022
Jolynn Tumolo
A Class II recall has been issued for a prescription drug used in the treatment of various cancers.
A Class II recall has been issued for a prescription drug used in the treatment of various cancers.
A Class II recall has been...
05/19/2022
Pharmacy Learning Network
News
Remdesivir-Tocilizumab May Be Preferable to Dexamethasone for Severe COVID-19
05/17/2022
Jolynn Tumolo
Researchers compared rates of mortality, hospital lengths of stay, and other outcomes in patients with severe COVID-19 treated with combination remdesivir-tocilizumab or dexamethasone.
Researchers compared rates of mortality, hospital lengths of stay, and other outcomes in patients with severe COVID-19 treated with combination remdesivir-tocilizumab or dexamethasone.
Researchers compared rates of...
05/17/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use